Abstract
Osteoarthritis is a significant cause of chronic pain in the elderly population with hip osteoarthritis as one of the main causes of functional disability and joint pain in adults older than 55 years. Recently, platelet rich plasma (PRP) injections have been introduced for treatment of osteoarthritis. The aim of this systematic review is to assess its effectiveness in the management of hip osteoarthritis. We performed a search of the literature for published prospective studies that assessed the effectiveness of PRP injections in the treatment of hip osteoarthritis, with a minimum follow-up of 3 months. Primary outcome measures were WOMAC and VAS scores. Five trials were identified with 185 patients undergoing treatment with ultrasound-guided intra-articular injections of PRP, compared with patients treated with hyaluronic acid alone (n = 148) or hyaluronic acid combined with PRP (n = 31) in one study. PRP was shown to improve patient outcome scores at follow-up at 6 and 12 months; however, there was no significant difference seen between patients treated with PRP or hyaluronic acid alone. Following this systematic review, we cannot currently recommend the use of intra-articular injections of PRP for the treatment of hip OA. Given that intra-articular steroid injections are the only such injection recommended by international guidelines for the treatment of hip OA, further studies comparing PRP to steroid would be of benefit to determine the value of PRP injections in hip OA.
Similar content being viewed by others
References
Song J, Chang RW, Dunlop DD (2006) Population impact of arthritis on disability in older adults. Arthritis Rheum 55(2):248–255
Roux CH, Saraux A, Mazieres B et al (2008) Screening for hip and knee osteoarthritis in the general population: predictive value of a questionnaire and prevalence estimates. Ann Rheum Dis 67(10):1406–1411
Hochberg MC, Altman RD, Brandt KD et al (1995) Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum 38(11):1541–1546
Richy F, Bruyere O, Ethgen O et al (2004) Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann Rheum Dis 63(7):759–766
McCabe PS, Maricar N, Parkes MJ et al (2016) The efficacy of intra-articular steroids in hip osteoarthritis: a systematic review. Osteoarthr Cartil 24(9):1509–1517
Letizia Mauro G, Scaturro D, Sanfilippo A, Benedetti MG (2018) Intra-articular hyaluronic acid injections for hip osteoarthritis. J Biol Regul Homeost Agents 32(5):1303–1309
Migliore A, Granata M, Tormenta S et al (2011) Hip viscosupplementation under ultra-sound guidance reduces NSAID consumption in symptomatic hip osteoarthritis patients in a long follow-up. Data from Italian registry. Eur Rev Med Pharmacol Sci 15(1):25–34
Dziedzic KS, Healey EL, Porcheret M et al (2018) Implementing core NICE guidelines for osteoarthritis in primary care with a model consultation (MOSAICS): a cluster randomised controlled trial. Osteoarthr Cartil 26(1):43–53
Pauly S, Klatte-Schulz F, Stahnke K et al (2018) The effect of autologous platelet rich plasma on tenocytes of the human rotator cuff. BMC Musculoskelet Disord 19(1):422
Rabago D, Best TM, Zgierska AE et al (2009) A systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet-rich plasma. Br J Sports Med 43(7):471–481
Altan E, Aydin K, Erkocak O et al (2014) The effect of platelet-rich plasma on osteochondral defects treated with mosaicplasty. Int Orthop 38(6):1321–1328
Sun Y, Feng Y, Zhang CQ et al (2010) The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop 34(4):589–597
Sanchez M, Guadilla J, Fiz N, Andia I (2012) Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology (Oxford) 51(1):144–150
Battaglia M, Guaraldi F, Vannini F, Rossi G et al (2013) Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics 36(12):e1501–e1508
Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16(4):494–502
Di Sante L et al (2016) Intra-articular hyaluronic acid vs platelet-rich plasma in the treatment of hip osteoarthritis. Med Ultrason 18(4):463–468
Altman R, Alarcón G, Appelrouth D et al (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34(5):505–514
Dallari D, Stagni C, Rani N et al (2016) Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: a randomized controlled study. Am J Sports Med 44(3):664–671
Murray DJ, Javed S, Jain N et al (2015) Platelet-rich plasma injections in treating lateral epicondylosis: a review of the recent evidence. J Hand Microsurg 7(2):320–325
Iagnocco A, Naredo E (2012) Osteoarthritis: research update and clinical applications. Rheumatology (Oxford) 51(Suppl 7):vii2–vii5
Author information
Authors and Affiliations
Contributions
BS and LG developed the idea for the study. MB and PM performed the searches and study review. All authors were involved in the analysis of the studies. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
Nil.
Ethics approval and consent to participate
Not applicable (systematic review).
Consent for publication
No personal data included.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key points
• The use of platelet-rich plasma as a treatment modality has expanded so quickly that the research into its efficacy lags far behind.
• The goal of this study is to determine if the use of PRP in hip osteoarthritis is a treatment that will benefit patients suffering from a debilitating illness.
• This study cannot support the routine use of PRP in the treatment of hip osteoarthritis based on the studies performed to date.
Rights and permissions
About this article
Cite this article
Berney, M., McCarroll, P., Glynn, L. et al. Platelet-rich plasma injections for hip osteoarthritis: a review of the evidence. Ir J Med Sci 190, 1021–1025 (2021). https://doi.org/10.1007/s11845-020-02388-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-020-02388-z